Japan's Nikkei 225 stayed near a
two-week high, while the yen rose as high as 119.99 against the US dollar,
after the BoJ held its monetary policy unchanged.
Tokyo-based pharmaceutical company Eisai rallied nearly 2 percent after
it was granted an additional patent for its Belviq drug. Following the news,
Eisai's US partner Arena Pharmaceuticals bolstered 3.9 percent overnight on the
Nasdaq.
www.capvision.co.in/freetrial.php
9713344666
No comments:
Post a Comment